Imagine a world where the next SARS or Ebola is caught before it spreads. That's the promise of the One Health approach, which connects veterinarians, doctors, and environmental scientists to track diseases at their source. A new review of existing research explains how this cross-sector teamwork, backed by tools like PCR tests, AI, and mobile health apps, can spot pathogens faster and predict outbreaks.
The review looked at how countries have used One Health diagnostics for diseases like Hendra virus and COVID-19. It found that when veterinary, public health, and environmental groups share data and work together, they can detect threats earlier and respond more effectively. Technologies like genomic sequencing and real-time monitoring have made field diagnostics quicker and more accurate.
But the review also highlights big challenges. Many countries still have fragmented surveillance systems, limited resources in low-income areas, and poor data sharing. Without standardized rules and sustained investment, the full potential of One Health remains out of reach.
This isn't a clinical trial with hard numbers. It's a summary of case studies and expert opinions. Still, it offers a clear roadmap: if we want to prevent the next pandemic, we need to break down silos and invest in connected health systems now.
Common questions
What is the One Health approach?
One Health is a way of working that brings together experts in human health, animal health, and the environment. The idea is that diseases often jump between animals and people, so monitoring all three areas can help catch outbreaks early. This review says it relies on coordinated efforts among veterinary, public health, and environmental sectors.
What diseases does this approach help with?
The review looked at zoonotic diseases, which are infections that spread from animals to humans. Examples include SARS, Ebola, Hendra virus, and COVID-19. By tracking these diseases in animals and the environment, health officials may be able to spot them before they cause widespread illness in people.
What technologies are used in One Health diagnostics?
The review mentions several tools that have improved disease detection. These include PCR tests, next-generation sequencing (NGS), metagenomics, artificial intelligence (AI), geographic information systems (GIS), mobile health (mHealth), biosensors, and point-of-care testing. These technologies help with real-time monitoring, field diagnostics, and outbreak prediction.
What are the main barriers to using One Health?
The review points to several challenges. These include inadequate adherence to standardized data-sharing principles, fragmented surveillance systems, limited infrastructure in low-resource settings, and insufficient interdisciplinary integration. In other words, different groups don't always share information well, and poorer areas lack the tools and training needed.
Is this review based on new clinical trial data?
No. This is a narrative review, which means it summarizes existing literature and case studies. It does not provide primary clinical trial data or direct evidence of causality. So while it offers useful insights, the findings are based on what other researchers have already reported, not on a new experiment.
